Vaccinations substantially declined during March to May 2020; increase seen in June to September, but not enough to catch up
CDC Calls Emergency Meeting on Heart Inflammation Link to COVID-19 Vaccines
Agency has identified 226 reports so far that may meet its ‘working case definition’ of myocarditis and pericarditis
Recent Increase Seen in COVID-19-Linked Hospitalization for Teens
Of those likely hospitalized primarily for COVID-19 during Jan.1 to March 31, 2021, 31.4 percent were admitted to ICU
Case Series Reports Myocarditis After Second Dose of COVID-19 Vaccine
Seven cases of acute myocarditis, myopericarditis identified in healthy male teens within four days after second Pfizer-BioNTech dose
BNT162b2 Vaccine Safe, Effective for Teens Aged 12 to 15 Years
Vaccine efficacy was 100 percent; no cases of COVID-19 with onset of seven or more days after dose 2 seen among BNT162b2 recipients
Moderna COVID-19 Vaccine Highly Effective in Children 12 and Older
Side effects among adolescents who received the Moderna vaccine were similar to those reported in adults
CDC Investigating Heart Problems in Teens, Young Adults After COVID-19 Vaccination
Health care providers should watch for unusual heart symptoms among young people who have just received the vaccine
Pfizer Vaccine Given Final Approval for Use in Adolescents
News comes as COVID-19 deaths are now averaging around 600 per day, the lowest tally since early July
FDA Approves Emergency Use of Pfizer Vaccine for Those Aged 12 to 15
Vaccination side effects comparable to those seen in trial participants ages 16 to 25 years
Canada Approves Pfizer COVID-19 Vaccine for Children Ages 12 to 15
Chief medical adviser at Health Canada says evidence is that the vaccine is safe and effective in the younger age group